Skip to main content
Sarah Leary, MD, Pediatric Hematology & Oncology, Seattle, WA, Seattle Children's Hospital

SarahE.LearyMD

Pediatric Hematology & Oncology Seattle, WA

Professor of Pediatrics, University of Washington School of Medicine

Dr. Leary is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Leary's full profile

Already have an account?

Education & Training

  • University of Tennessee College of Medicine
    University of Tennessee College of MedicineFellowship, Pediatric Hematology/Oncology, 2004 - 2007
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineResidency, Pediatrics, 2001 - 2004
  • University of Tennessee Health Science Center College of Medicine
    University of Tennessee Health Science Center College of MedicineClass of 2001

Certifications & Licensure

  • AK State Medical License
    AK State Medical License 2021 - 2022
  • WA State Medical License
    WA State Medical License 2009 - 2022
  • MD State Medical License
    MD State Medical License 2007 - 2010
  • DC State Medical License
    DC State Medical License 2007 - 2010
  • VA State Medical License
    VA State Medical License 2007 - 2010
  • TN State Medical License
    TN State Medical License 2004 - 2008
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Heterogeneity Within the PF-EPN-B Ependymoma Subgroup  
    Andrew Grossbach, Vijay Ramaswamy, Benjamin Lu, Mariarita Santi, Caterina Giannini, Linda M Liau, Terri S Armstrong, Sarah Leary, Matthias A Karajannis, Kenneth Aldape..., Acta Neuropathologica

Press Mentions

  • Blaze Bioscience Kicks off Pivotal Trial for Brain Tumor-Illumination Tech
    Blaze Bioscience Kicks off Pivotal Trial for Brain Tumor-Illumination TechNovember 28th, 2018
  • Gateway for Cancer Research Announces Completion of Phase I Clinical Trial Using “Tumor Paint” in Pediatric Brain Cancer Surgery
    Gateway for Cancer Research Announces Completion of Phase I Clinical Trial Using “Tumor Paint” in Pediatric Brain Cancer SurgeryApril 24th, 2018
  • Gateway for Cancer Research Funds Novel, Patient-Centric Phase I and Phase II Clinical Trials with 99 Cents of Every Dollar Received
    Gateway for Cancer Research Funds Novel, Patient-Centric Phase I and Phase II Clinical Trials with 99 Cents of Every Dollar ReceivedOctober 31st, 2017
  • Join now to see all

Hospital Affiliations